MedTrace Logo

Effect of General Anesthesia Method on Cardiac Risk Patients on Ischemia Modified Markers

NCT05662163 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2022-12-22

No results posted yet for this study

Summary

To examine the effects of the general anesthesia method chosen in non-cardiac surgical operations of patients with cardiac risk on the levels of cardiac markers

Conditions

  • Anesthesia

Interventions

PROCEDURE

TIVA

Anesthesia will be maintained with propofol (6-10 mg/kg/hour) and remifentanil (0.1-0.3 μg/kg/min).

PROCEDURE

GENERAL ANESTHESIA

Anesthesia will be maintained with sevoflurane (2 ml/min) 50% oxygen and remifentanil (0.1-0.3 μg/kg/min).

Sponsors & Collaborators

  • Ataturk University

    lead OTHER

Principal Investigators

  • Canan Atalat · Ataturk University

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-12-30
Primary Completion
2023-06-30
Completion
2023-12-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05662163 on ClinicalTrials.gov